Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors

Chinese Medical Journal (Taipei)

Volumn 62, Issue 10, 1999, Pages 695-702

  Liu, Fu Shing ^a   Chen, Jung Ta ^a   Liu, Shih Chia Chang ^b   Shih, Ai ^a   Shih, Rocky Tai Ping ^a   Ho, Esther Shih Chu ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Ki 67; Ovarian germ cell tumor; Prognosis; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; OVARY TUMOR; PROGNOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GERMINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; OVARIAN NEOPLASMS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0032876493     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Talerman A. Germ cell tumors. In: Sasano N, ed. Gynecological Tumors: Current Topics in Pathology, Vol 85. Berlin: Springer-Verlag, 1992:165-202.
2. Talerman A. Germ cell tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag, 1994:849-914.
3. Williams SD. Ovarian germ cell tumors. In: Rubin SC, Sutton GP, eds. Ovarian Cancer. New York: McGraw-Hill, 1993:391-404.
4. el-Naggar AK, Ro JY, McLemore D, Ayala AG, Batsakis JG. DNA ploidy in testicular germ cell neoplasms. Histogenetic and clinical implications. Am J Surg Pathol 1992;16: 611-8.
5. Nativ O, Winkler HZ, Farrow GM, Themeau TM, Lieber MM. Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology 1994;43:197-202.
6. Ulbright TM, Orazi A, de-Riese W, de-Riese C, Messemer JE, Foster RS, et al. The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. Mod Pathol 1994;7:64-8.
7. Albers P, Ulbright TM, Albers J, Miller GA, Orazi A, Crabtree WN, et al. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. J Urol 1996; 155:579-86.
8. Albers P, Orazi A, Ulbright TM, Miller GA, Haidar JH, Donohue JP, Foster RS. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod Pathol 1995;8:492-7.
9. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121: 2228-34.
10. Matthews M, Bernstein R, Franza B, Garrels J. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;303:374-6.
11. Waga S, Hannon GJ, Beach D, Stiliman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574-8.
12. Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994;371: 534-7.
13. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
14. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
15. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
16. Haerslev T, Jacobsen GK, Zedeler K. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas. Breast Cancer Res Treat 1996;37:101-13.
17. 2 tests. Biometrics 1954;10:417-51.
18. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955;11:375-85.
19. Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastasis, dissemination, and long-term survival. Radiother Oncol 1989;15:1-18.
20. Yu CCW, Filipe MI. Update on proliferation-associated antibodies applicable to formalin fixed paraffin embedded tissue and their clinical applications. Histochem J 1993;25: 843-53.
21. Ng IOL, Lai ECS, Fan ST, Ng M, Chan ASY, So MKP. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994;73. 2268-74.
22. Tahan S, Neuberg D, Dieffenbach A, Yacoub L. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 1993;71:3552-9.
23. Siitonen S, Isola J, Rantala I, Helin H. Intratumor variation in cell proliferation in breast carcinoma as determined by anti-PCNA monoclonal antibody and automated image analysis. Am J Clin Pathol 1993;99:226-31.
24. Williams SD, Gershenson DM, Horowitz CJ, Scully RE. Ovarian germ-cell tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia: Lippincott-Raven, 1997:987-1002.